Detalhe da pesquisa
1.
Targeting N-cadherin (CDH2) and the malignant bone marrow microenvironment in acute leukaemia.
Expert Rev Mol Med
; 25: e16, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37132370
2.
Next generation organoid engineering to replace animals in cancer drug testing.
Biochem Pharmacol
; 213: 115586, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37164297
3.
A human mesenchymal spheroid prototype to replace moderate severity animal procedures in leukaemia drug testing.
F1000Res
; 11: 1280, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-38046539
4.
hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia.
Cell Rep Med
; 3(8): 100717, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977468